Evaluating experimental cerebral malaria using oxidative stress indicator OKD48 mice

International Journal for Parasitology

Volumn 44, Issue 10, 2014, Pages 681-685

  Imai, Takashi ^a   Iwawaki, Takao ^a   Akai, Ryoko ^a   Suzue, Kazutomo ^a   Hirai, Makoto ^a   Taniguchi, Tomoyo ^a   Okada, Hiroko ^a   Hisaeda, Hajime ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Experimental cerebral malaria; In vivo imaging; Malaria; Oxidative stress

Indexed keywords

HEME OXYGENASE 1; PYRIMETHAMINE; TRANSCRIPTION FACTOR NRF2; ANTIMALARIAL AGENT;

BRAIN; EXPERIMENTAL STUDY; MALARIA; PROTOZOAN; RODENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATAXIA; BIOLUMINESCENCE; BLOOD BRAIN BARRIER; BRAIN MALARIA; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CONVULSION; FEMALE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PARAPLEGIA; PARASITEMIA; PLASMODIUM BERGHEI INFECTION; PLASMODIUM YOELII; SURVIVAL RATE; TRANSCRIPTION INITIATION; ANIMAL; BRAIN; INBRED MOUSE STRAIN; LUMINESCENCE; MALARIA; METABOLISM; PARASITOLOGY; PATHOLOGY; PHYSIOLOGY; PLASMODIUM BERGHEI;

MUS; PLASMODIUM BERGHEI;

ANIMALS; ANTIMALARIALS; BRAIN; LUMINESCENT MEASUREMENTS; MALARIA, CEREBRAL; MICE; MICE, INBRED STRAINS; OXIDATIVE STRESS; PLASMODIUM BERGHEI; PLASMODIUM YOELII; PYRIMETHAMINE;

EID: 84906066753     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2014.06.002     Document Type: Article

References (25)

1. Alam J., Stewart D., Touchard C., Boinapally S., Choi A.M., Cook J.L. Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J. Biol. Chem. 1999, 274:26071-26078.
2. Amante F.H., Haque A., Stanley A.C., Rivera Fde L., Randall L.M., Wilson Y.A., Yeo G., Pieper C., Crabb B.S., de Koning-Ward T.F., Lundie R.J., Good M.F., Pinzon-Charry A., Pearson M.S., Duke M.G., McManus D.P., Loukas A., Hill G.R., Engwerda C.R. Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria. J. Immunol. 2010, 185:3632-3642.
3. Baptista F.G., Pamplona A., Pena A.C., Mota M.M., Pied S., Vigario A.M. Accumulation of Plasmodium berghei-infected red blood cells in the brain is crucial for the development of cerebral malaria in mice. Infect. Immun. 2010, 78:4033-4039.
4. Becker K., Tilley L., Vennerstrom J.L., Roberts D., Rogerson S., Ginsburg H. Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. Int. J. Parasitol. 2004, 34:163-189.
5. Belnoue E., Kayibanda M., Vigario A.M., Deschemin J.C., van Rooijen N., Viguier M., Snounou G., Renia L. On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J. Immunol. 2002, 169:6369-6375.
6. Craig A.G., Grau G.E., Janse C., Kazura J.W., Milner D., Barnwell J.W., Turner G., Langhorne J. The role of animal models for research on severe malaria. PLoS Pathog. 2012, 8:e1002401.
7. Cullinan S.B., Gordan J.D., Jin J., Harper J.W., Diehl J.A. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol. Cell. Biol. 2004, 24:8477-8486.
8. Hearn J., Rayment N., Landon D.N., Katz D.R., de Souza J.B. Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature. Infect. Immun. 2000, 68:5364-5376.
9. Imai T., Shen J., Chou B., Duan X., Tu L., Tetsutani K., Moriya C., Ishida H., Hamano S., Shimokawa C., Hisaeda H., Himeno K. Involvement of CD8+ T cells in protective immunity against murine blood-stage infection with Plasmodium yoelii 17XL strain. Eur. J. Immunol. 2010, 40:1053-1061.
10. Ishida H., Matsuzaki-Moriya C., Imai T., Yanagisawa K., Nojima Y., Suzue K., Hirai M., Iwakura Y., Yoshimura A., Hamano S., Shimokawa C., Hisaeda H. Development of experimental cerebral malaria is independent of IL-23 and IL-17. Biochem. Biophys. Res. Commun. 2010, 402:790-795.
11. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., Oyake T., Hayashi N., Satoh K., Hatayama I., Yamamoto M., Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 1997, 236:313-322.
12. Lackner P., Beer R., Heussler V., Goebel G., Rudzki D., Helbok R., Tannich E., Schmutzhard E. Behavioural and histopathological alterations in mice with cerebral malaria. Neuropathol. Appl. Neurobiol. 2006, 32:177-188.
13. Miyakoda M., Kimura D., Yuda M., Chinzei Y., Shibata Y., Honma K., Yui K. Malaria-specific and nonspecific activation of CD8+ T cells during blood stage of Plasmodium berghei infection. J. Immunol. 2008, 181:1420-1428.
14. Oikawa D., Akai R., Tokuda M., Iwawaki T. A transgenic mouse model for monitoring oxidative stress. Sci. Rep. 2012, 2:229.
15. Ong P.K., Melchior B., Martins Y.C., Hofer A., Orjuela-Sanchez P., Cabrales P., Zanini G.M., Frangos J.A., Carvalho L.J. Nitric oxide synthase dysfunction contributes to impaired cerebroarteriolar reactivity in experimental cerebral malaria. PLoS Pathog. 2013, 9:e1003444.
16. Pamplona A., Ferreira A., Balla J., Jeney V., Balla G., Epiphanio S., Chora A., Rodrigues C.D., Gregoire I.P., Cunha-Rodrigues M., Portugal S., Soares M.P., Mota M.M. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat. Med. 2007, 13:703-710.
17. Percario S., Moreira D.R., Gomes B.A., Ferreira M.E., Goncalves A.C., Laurindo P.S., Vilhena T.C., Dolabela M.F., Green M.D. Oxidative stress in malaria. Int. J. Mol. Sci. 2012, 13:16346-16372.
18. Reis P.A., Comim C.M., Hermani F., Silva B., Barichello T., Portella A.C., Gomes F.C., Sab I.M., Frutuoso V.S., Oliveira M.F., Bozza P.T., Bozza F.A., Dal-Pizzol F., Zimmerman G.A., Quevedo J., Castro-Faria-Neto H.C. Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy. PLoS Pathog. 2010, 6:e1000963.
19. Rogers D.C., Fisher E.M., Brown S.D., Peters J., Hunter A.J., Martin J.E. Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm. Genome 1997, 8:711-713.
20. Sies H. Oxidative stress: from basic research to clinical application. Am. J. Med. 1991, 91:31S-38S.
21. Suzuki M., Waki S., Igarashi I., Takagi T., Miyagami T., Nakazawa S. An alternative approach to malaria vaccine with a permanent attenuated mutant from a high virulence Plasmodium berghei strain. Zentralbl. Bakteriol. Mikrobiol. Hygi. A 1987, 264:319-325.
22. Tenhunen R., Marver H.S., Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci. U.S.A. 1968, 61:748-755.
23. Thumwood C.M., Hunt N.H., Clark I.A., Cowden W.B. Breakdown of the blood-brain barrier in murine cerebral malaria. Parasitology 1988, 96(Pt 3):579-589.
24. Wilson T., Edeson J.F. Treatment of acute malaria with pyrimethamine. Br. Med. J. 1953, 1:253-255.
25. Yanez D.M., Manning D.D., Cooley A.J., Weidanz W.P., van der Heyde H.C. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J. Immunol. 1996, 157:1620-1624.